Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Mark Copley is Sales Director at Copley Scientific.

Articles

The role of add-on devices and how they affect drug delivery with a pressurized metered dose inhaler.

Exploring Newly Introduced Methods for Testing MDIs with Add-On Devices

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

A surge in generic drug applications is testing FDA?s ability to reduce the backlog of ANDAs.

FDA Strategies Designed to Speed Generic Drug Approvals

The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.

NIH Launches Human Safety Study of Ebola Vaccine Candidate

Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.

Report Predicts Generics Production Return to US

The European system for assessing drugs will be used as a model internationally.

Europe Leads Generic-Drugs Assessment Project

EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.

EMA Invites Comments on New Guidance for Vaccine Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Customers are looking to reduce risk, increase performance, and optimize productivity.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.

Changes and Challenges for Generic Drugs

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts from Capsugel and Catalent discuss the rationale of using lipid0basd formulations to improve the oral bioavailability of poorly soluble drugs.

Bioavailability Enhancement with Lipid-Based Drug-Delivery Systems

With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.